Longitudinal evaluation of the psychomotor syndrome in schizophrenia

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 26, Issue 4, 2014, Pages 359-368

  Docx, Lise ^a   Sabbe, Bernard ^a   Fransen, Erik ^a   Bervoets, Chris ^a   Hulstijn, Wouter ^a   Van Den Bossche, Maarten J A ^a   Vermeylen, Sara ^a   Temmerman, Anke ^a   Morsel, Anne ^a   Morrens, Manuel ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR DISORDER; SCHIZOPHRENIA; ADOLESCENT; COMPLICATION; MIDDLE AGED; NEUROLOGIC EXAMINATION; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMOTOR DISORDERS; PSYCHOMOTOR PERFORMANCE; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR DISORDERS; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84920940134     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.13020027     Document Type: Article

References (45)

1. Tandon R, Nasrallah HA, Keshavan MS: Schizophrenia, “just the facts” 4. Clinical features and conceptualization. Schizophr Res 2009; 110:1–23
2. Isohanni M, Murray GK, Jokelainen J, et al: The persistence of developmental markers in childhood and adolescence and risk for schizophrenic psychoses in adult life. A 34-year follow-up of the Northern Finland 1966 birth cohort. Schizophr Res 2004; 71:213–225
3. Rosso IM, Bearden CE, Hollister JM, et al: Childhood neuromotor dysfunction in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull 2000; 26:367–378
4. Schiffman J, Walker E, Ekstrom M, et al: Childhood videotaped social and neuromotor precursors of schizophrenia: a prospective investigation. Am J Psychiatry 2004; 161:2021–2027
5. Sørensen HJ, Mortensen EL, Schiffman J, et al: Early developmental milestones and risk of schizophrenia: a 45-year followup of the Copenhagen Perinatal Cohort. Schizophr Res 2010; 118:41–47
6. Mittal VA, Neumann C, Saczawa M, et al: Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. Arch Gen Psychiatry 2008; 65:165–171
7. Docx L, Morrens M, Bervoets C, et al: Parsing the components of the psychomotor syndrome in schizophrenia. Acta Psychiatr Scand 2012; 126:256–265
8. Peralta V, Cuesta MJ: Neuromotor abnormalities in neurolepticnaive psychotic patients: antecedents, clinical correlates, and prediction of treatment response. Compr Psychiatry 2011; 52: 139–145
9. Weinberger DR: From neuropathology to neurodevelopment. Lancet 1995; 346:552–557
10. Bachmann S, Bottmer C, Schröder J: Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry 2005; 162:2337–2343
11. Boks MP, Selten JP, Leask S, et al: The 2-year stability of neurological soft signs after a first episode of non-affective psychosis. Eur Psychiatry 2006; 21:288–290
12. Chen EY, Hui CL, Chan RC, et al: A 3-year prospective study of neurological soft signs in first-episode schizophrenia. Schizophr Res 2005; 75:45–54
13. Heaton RK, Gladsjo JA, Palmer BW, et al: Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001; 58:24–32
14. Hoff AL, Svetina C, Shields G, et al: Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr Res 2005; 78:27–34
15. Hughes C, Kumari V, Soni W, et al: Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res 2003; 59:137–146
16. Madsen AL, Vorstrup S, Rubin P, et al: Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand 1999; 100:119–125
17. Mayoral M, Bombín I, Castro-Fornieles J, et al: Longitudinal study of neurological soft signs in first-episode early-onset psychosis. J Child Psychol Psychiatry 2012; 53:323–331
18. Rodríguez-Sánchez JM, Pérez-Iglesias R, González-Blanch C, et al: 1-year follow-up study of cognitive function in first-episode non-affective psychosis. Schizophr Res 2008; 104:165–174
19. Smith RC, Hussain MI, Chowdhury SA, et al: Stability of neurological soft signs in chronically hospitalized schizophrenic patients. J Neuropsychiatry Clin Neurosci 1999; 11:91–96
20. Whitty P, Clarke M, Browne S, et al: Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychol Med 2003; 33:1479–1484
21. Chen EY, Kwok CL, Au JW, et al: Progressive deterioration of soft neurological signs in chronic schizophrenic patients. Acta Psychiatr Scand 2000; 102:342–349
22. Gold S, Arndt S, Nopoulos P, et al: Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry 1999; 156:1342–1348
23. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261–276
24. Bush G, Fink M, Petrides G, et al: Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand 1996; 93:129–136
25. Gerlach J, Korsgaard S, Clemmesen P, et al: The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand 1993; 87:244–252
26. Widlocher D, Gohzlan A: The measurement of retardation in depression, in Human Psychopharmacology: Measures and Methods. vol. 2. Edited by Hindmarch I, Sotnier PD. New York, John Wiley & Sons, 1989
27. Buchanan RW, Heinrichs DW: The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 1989; 27: 335–350
28. Destoop M, De Bruijn ER, Hulstijn W, et al: A cognitive neuropsychiatric analysis of psychomotor symptoms in major depression and schizophrenia. Acta Neurol Belg 2009; 109:262–270
29. Morrens M, Hulstijn W, Matton C, et al: Delineating psychomotor slowing from reduced processing speed in schizophrenia. Cogn Neuropsychiatry 2008; 13:457–471
30. Schrijvers D, de Bruijn ER, Maas Y, et al: Action monitoring in major depressive disorder with psychomotor retardation. Cortex 2008; 44:569–579
31. Peralta V, Cuesta MJ: Negative parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr Res 1999; 40:245–253
32. Peralta V, Cuesta MJ: Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr Res 2001; 47:107–116
33. Ungvari GS, Goggins W, Leung SK, et al: Schizophrenia with prominent catatonic features (‘catatonic schizophrenia’) III. Latent class analysis of the catatonic syndrome. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33:81–85
34. Walther S, Horn H, Razavi N, et al: Quantitative motor activity differentiates schizophrenia subtypes. Neuropsychobiology 2009; 60:80–86
35. Walther S, Koschorke P, Horn H, et al: Objectively measures motor activity in schizophrenia challenges the validity of expert ratings. Psychol Res 2009; 169:187–190
36. Walther S, Strik W: Motor symptoms and schizophrenia. Neuropsychobiology 2012; 66:77–92
37. Morrens M, Hulstijn W, Sabbe B: Psychomotor slowing in schizophrenia. Schizophr Bull 2007; 33:1038–1053
38. Willingham DB: A neuropsychological theory of motor skill learning. Psychol Rev 1998; 105:558–584
39. Delevoye-Turrell Y, Giersch A, Wing AM, et al: Motor fluency deficits in the sequencing of actions in schizophrenia. J Abnorm Psychol 2007; 116:56–64
40. Grootens KP, Vermeeren L, Verkes RJ, et al: Psychomotor planning is deficient in recent-onset schizophrenia. Schizophr Res 2009; 107:294–302
41. Morrens M, Hulstijn W, Sabbe B: The effects of atypical and conventional antipsychotics on reduced processing speed and psychomotor slowing in schizophrenia: a cross-sectional exploratory study. Clin Ther 2008; 30:684–692
42. Whitty PF, Owoeye O, Waddington JL: Neurological signs and involuntarymovements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull 2009; 35:415–424
43. Green MF, Kern RS, Heaton RK: Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 2004; 72:41–51
44. Ungvari GS, Leung SK, Ng FS, et al: Schizophrenia withprominent catatonic features (‘catatonic schizophrenia’): I. Demographic and clinical correlates in the chronic phase. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:27–38
45. Whitty P, Clarke M, McTigue O, et al: Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophr Res 2006; 86:110–117